IDEAS home Printed from https://ideas.repec.org/a/sae/clnure/v16y2007i1p58-71.html
   My bibliography  Save this article

Medication Use and Symptoms in Individuals With Mitral Valve Prolapse Syndrome

Author

Listed:
  • Kristine A. Scordo

    (Wright State University, Dayton, Ohio, kscordo@cinci.rr.com)

Abstract

Mitral valve prolapse (MVP) is a common valvular heart disease associated with a variety of frightening symptoms. Beta-adrenergic blockers along with calcium channel blockers and anxiolytics are widely used to treat symptoms associated with MVPS despite a lack of evidence that supports their efficacy. This study examined the relationship between prescribed medication use and frequency and intensity of MVPS symptoms. A descriptive cross-sectional survey design was used. Descriptive statistics and Cramèr’s V correlational analysis were used to answer the research questions. Self-completed questionnaires were mailed to 2,282 MVPS individuals older than 21 years of age throughout the United States and Canada previously diagnosed with MVPS. Of the 837 participants, 337 (40%) were taking one or more medications. Although there were significant positive correlations between anxiety and calcium channel blockers, chest pain and digoxin, and mood swings and digoxin, the correlations were very weak.

Suggested Citation

  • Kristine A. Scordo, 2007. "Medication Use and Symptoms in Individuals With Mitral Valve Prolapse Syndrome," Clinical Nursing Research, , vol. 16(1), pages 58-71, February.
    • Handle: RePEc:sae:clnure:v:16:y:2007:i:1:p:58-71
    DOI: 10.1177/1054773806295240
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/1054773806295240
    Download Restriction: no
    File URL: https://libkey.io/10.1177/1054773806295240?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:clnure:v:16:y:2007:i:1:p:58-71. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.